References
- Neu HC. The emergence of bacterial resistance and its influence on empiric therapy. Rev Infect Dis 1983; 5 (Suppl): 9–20.
- Harris AA, Levin S, Trenholme GM. Selected aspects of nosocomial infections in the 1980s. Am J Med 1984; 77: 3–9.
- Neu HC. Changing mechanisms of bacterial resistance. Am J Med 1984; 77: 11–23.
- Neu HC. Resistance of bacteria due to β-lactamases. Proceedings of the 14th International Congress of Chemotherapy. Kyoto. Japan. 5–12, 1985.
- Selwin S. The β-lactam antibiotics: penicillin and cephalosporins in perspective. London: Hodder and Stoughton. 1980: 299–301, 311.
- Greenwood D, Eley A. In vitro evaluation of sulbactam, a penicillanic acid sulphone with β-lactamases inhibitory properties. J Antimicrob Chemother 1982; 10: 117–123.
- Li JT, Moosden F, Williams JD. Effects of inhibitors of beta-lactamases extracts and on intact cells. J Antimicrob Chemother 1982; 4: 287–296.
- Jones RN. In vitro evaluations of aminopenicillin/β-lactamase inhibitor combinations. Drugs 1988; 35: 17–26.
- Pitts NE, Knirsh AK, Lees L, McBride TJ, Mehta DJ. Experience with sulbactam/ampicillin. Proceedings of the 14th International Congress of Chemotherapy. Kyoto. Japan. 25–34, 1985.
- Guneren MF. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial. Drugs 1988; 35: 57–68.
- Shimada K. Clinical evaluation of sulbactam/ampicillin in Japan. Diagn Microbiol Infect Dis 1989; 12: 171–174.